Climb Bio, Inc.
Pharmaceutical company · Wellesley Hills, Massachusetts, United States · Nasdaq: CLYM
Climb Bio, Inc. is a pharmaceutical company headquartered in Wellesley Hills, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker CLYM. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2026.
Climb Bio at a glance
What does Climb Bio do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $110.1 million sold (2026).
Frequently asked questions about Climb Bio
Where is Climb Bio headquartered?
Climb Bio, Inc. is headquartered in Wellesley Hills, Massachusetts, United States.
What does Climb Bio do?
Climb Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Climb Bio a public company?
Yes. Climb Bio, Inc. trades on Nasdaq under the ticker CLYM.
When was Climb Bio founded?
The earliest incorporation on record for Climb Bio, Inc. is in 2018, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.